The Hindu·3 min read·medium
Moderna begins first human trial of Bundibugyo Ebola vaccine
R
Reuters
✦AI Summary
Moderna has initiated the first human clinical trials for an experimental vaccine targeting the Bundibugyo Ebola virus. The study, funded in part by CEPI, aims to test the safety and immune response of the mRNA-1469 vaccine in healthy adults.
Moderna on Tuesday said it has begun its first human trial of an experimental vaccine to protect against Bundibugyo ebolavirus, a strain of Ebola that has killed more than 1,650 people so far and currently has no approved vaccine.
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in